Q4 2022 Biotest AG Earnings Call Transcript
Good morning, ladies and gentlemen. It's a pleasure to have you here today in Dreieich for our first hybrid meeting of the analyst conference. So welcome here in Dreieich, and welcome also the team's participants, they are here today from Germany, Spain, U.K. and the United States, so welcome. Today, it will be Michael Ramroth, CEO, to give an update on the ongoing business and a research and development update; and Ainhoa Zubiag,a, CFO of Biotest to give you an update on the plasma environment and also on the financials. With this, I'd like to hand over to Michael.
Yes. Thank you very much, and a warm welcome also from my side, especially to the early birds in the United States. So great that you are following us today. And you know all the long-term followers of you and some of you have been following Biotest since decades almost. You know that we always start with highlights, a summary of our presentation. And
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |